Literature DB >> 6253573

A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients.

M Lutzner, O Croissant, M F Ducasse, H Kreis, J Crosnier, G Orth.   

Abstract

We have observed 2 immunosuppressed renal allograft recipients with skin lesions induced by human papillomavirus type 5 (HPV-5). One recipient had multiple pityriasis versicolor-like (PV-like) skin lesions on his arms and trunk, and multiple Bowenoid in-situ skin cancers. The other had 2 warty lesions on the back of her fingers. Structural antigens of human papillomavirus type 5 (HPV-5) were identified in benign lesions from both patients by immunofluorescence. The histologic and ultrastructural features observed in lesions from both patients were similar to those previously seen in HPV-5-induced lesions occurring in patients with the rare disease epidermodysplasia verruciformis (EV). The severe form of EV is characterized by HPV-5-induced PV-like lesions, multiple skin cancers, and usually depressed cell-mediated immunity. The picture seen in one of our renal allograft recipients recalls this severe form of EV. HPV-5, until now, has been found only in EV patients. The role of this potentially oncogenic virus in skin cancers which are known to occur with increased frequency in immunosuppressed renal allograft recipients must be determined.

Entities:  

Mesh:

Year:  1980        PMID: 6253573     DOI: 10.1111/1523-1747.ep12531131

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Epidermodysplasia verruciformis (L-L, 1922) in a patient with systemic lupus erythematosus.

Authors:  T Tanigaki; R Kanda; K Sato
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Demonstration of human papillomavirus DNA in two keratoacanthomas.

Authors:  H Pfister; A Gassenmaier; P G Fuchs
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Demonstration of human papilloma virus type 2 DNA in Bowen's disease.

Authors:  H Pfister; E Haneke
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

Review 4.  Immunopathology of papillomavirus-induced tumors in different tissues.

Authors:  S Jablonska; G Orth; M A Lutzner
Journal:  Springer Semin Immunopathol       Date:  1982

Review 5.  Immunopathology of papillomavirus-induced warts and skin cancers in immunodepressed and immunosuppressed patients.

Authors:  M A Lutzner
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Human papillomavirus 25-related DNA in solitary keratoacanthoma.

Authors:  A Gassenmaier; H Pfister; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

7.  Papillomavirus DNA in warts of immunosuppressed renal allograft recipients.

Authors:  A Gassenmaier; P Fuchs; H Schell; H Pfister
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

8.  Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients.

Authors:  R J Berkhout; L M Tieben; H L Smits; J N Bavinck; B J Vermeer; J ter Schegget
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.

Authors:  A L Claudy; J L Touraine; D Mitanne
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 10.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.